NASDAQ: ZYNE Long Term Shareholder Notice: Investigation over Possible Wrongdoing at Zynerba Pharmaceuticals, Inc.
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Zynerba Pharmaceuticals, Inc..
View full press release